Fidaxomicin lite N-Demethyl Ivabradine Hydrochloride 5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol

5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol

10(3):318-323

Smiles: OC1(CN2CCC(COC3=NOC4=CC=CC(O[C@H]5COCC5)=C43)CC2)CCOCC1

29(6):1267-78

and the induction of tumor cell apoptosis

Fidaxomicin lite N-Demethyl Ivabradine Hydrochloride 5-c]pyridin-4-yl)-2-methylbut-3-yn-2-olFidaxomicin is the first in a new class of narrow spectrum macrocyclic antibiotic drugs. It is a fermentation product obtained from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesis. Fidaxomicin is non systemic, meaning it is minimally absorbed into the bloodstream, it is bactericidal, and it has demonstrated selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that